Gary G. Lu
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 35
- Acute Myeloid Leukemia Research 25
- Chronic Myeloid Leukemia Treatments 14
- Multiple Myeloma Research and Treatments 9
- Genetics 20
- Chronic Lymphocytic Leukemia Research 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Co-authors
- L. Jeffrey Medeiros (25 shared papers)Chung Shu Yang (4 shared papers)Carlos E. Bueso‐Ramos (12 shared papers)C. Cameron Yin (15 shared papers)Hang Xiao (2 shared papers)Huanyu Jin (2 shared papers)Guang‐Yu Yang (2 shared papers)Jie Liao (2 shared papers)
- Journals
- American Journal of Clinical Pathology (4 papers)Blood (3 papers)Leukemia Research (3 papers)Annals of Oncology (2 papers)Leukemia (2 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Gary G. Lu
71 papers receiving 1.7k citations
Gary G. Lu's Hit Papers
Peers
Comparison fields: 5 of 119
- Hematology 486
- Applied Microbiology and Biotechnology 71
- Genetics 271
- Pathology and Forensic Medicine 405
- Biochemistry 119
Countries citing papers authored by Gary G. Lu
This map shows the geographic impact of Gary G. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary G. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary G. Lu more than expected).
Fields of papers citing papers by Gary G. Lu
This network shows the impact of papers produced by Gary G. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary G. Lu. The network helps show where Gary G. Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary G. Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 211 | |
| 2 | Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2022 | 210 |
| 3 | 2020 | 99 | |
| 4 | 2012 | 94 | |
| 5 | Population-based, case-control study of blood C-peptide level and breast cancer risk. | 2001 | 75 |
| 6 | 2011 | 63 | |
| 7 | Cancer prevention by tea and tea polyphenols. | 2008 | 60 |
| 8 | 2004 | 53 | |
| 9 | 2012 | 51 | |
| 10 | 2003 | 51 | |
| 11 | 2013 | 51 | |
| 12 | 2008 | 48 | |
| 13 | 2010 | 47 | |
| 14 | 2012 | 43 | |
| 15 | 2014 | 35 | |
| 16 | 2014 | 35 | |
| 17 | 2014 | 35 | |
| 18 | 2013 | 34 | |
| 19 | 2009 | 30 | |
| 20 | 2016 | 29 |
About Gary G. Lu
Gary G. Lu is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 72 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (25 papers), Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Hematology (486 citations), Applied Microbiology and Biotechnology (71 citations), Genetics (271 citations), Pathology and Forensic Medicine (405 citations) and Biochemistry (119 citations). Gary G. Lu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include L. Jeffrey Medeiros, Chung Shu Yang, Carlos E. Bueso‐Ramos, C. Cameron Yin, Hang Xiao, Huanyu Jin, Guang‐Yu Yang, Jie Liao, Albert Cheung-Hoi Yu and Yu‐Kuo Chen. Their work appears in journals such as American Journal of Clinical Pathology, Blood, Leukemia Research, Annals of Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.